The 14 Billion Dose COVID-19 Manufacturing Challenge
The development of the first COVID-19 vaccines in 2020 was undoubtedly one of the greatest ever achievements of the biopharma sector and its partners, with the first vaccines discovered, tested ..... see more
Source : IN VIVO
Olainfarm Sets Out ‘Forward 2020-2025’ Strategy
Latvia’s Olainfarm Group has outlined a clear vision for its future operations in the form of its “Forward 2020-2025” strategy, which will “place more emphasis on development of the core ..... see more
Source : 'Generics Bulletin'
Sandoz CEO Takes Stock Of Generics Industry After A Year Of Lockdowns
One year after lockdowns swept across Europe, Sandoz Inc. CEO Richard Saynor has summarized the implications the crisis has had on the generics industry. In some areas new ..... see more
Source : 'Generics Bulletin'
Pandemic Perspectives: Cracks In Global Supply Chain Lead To Localization Trend
One year on from the formal designation by the World Health Organization of the coronavirus outbreak as a pandemic, the disruptive effects on the global pharmaceutical supply chain, especially for ..... see more
Source : IN VIVO
Indoco Aims For Growth Despite ‘Inconsistent Indian Pharma Market’
After predicting domestic growth on the back of an expected bounce back of the Indian pharma market, Indoco Remedies has now re-evaluated its position as the company believes that it ..... see more
Source : 'Generics Bulletin'
Revlon Watching For Color Cosmetics Rebound In 2021
The COVID pandemic’s impact on global color cosmetics consumption has done no favors for Revlon, Inc.’s namesake business, Portfolio brands such as Almay and SinfulColors, and Elizabeth Arden-branded products including ..... see more
Source : 'HBW Insight'
ROI For US With FDA's Emergency Use Approval Of Cue Health's OTC At-Home COVID-19 Test
The US Food and Drug Administration granted its first emergency use authorization for an OTC at-home molecular diagnostic test to Cue Health Inc. after investing $481m in the San Diego firm in ..... see more
Source : 'HBW Insight'
COVID-19 Pharmacovigilance Flexibilities 'Must Remain' In Non-EU Markets
The COVID-19 pandemic has driven changes in many areas of drug regulation, and pharmacovigilance has been no exception.It has resulted in some countries embracing electronic means for receiving safety documents, ..... see more
Source : 'The Pink Sheet'
Pink Sheet Podcast: Pre-Announced FDA Inspections, Vaccine Safety, On-Time Application Decisions
Pink Sheet senior writers Derrick Gingery and Sarah Karlin-Smith, Senior Editor Joanne Eglovitch and Executive Editor Nielsen Hobbs consider the impact of pre-announcing domestic inspections once the pandemic ends, look ..... see more
Source : 'The Pink Sheet'
Experts Look At How To Speed Approval Of Variant COVID-19 Vaccines
Companies seeking marketing approval of vaccines against variants of the SARS-CoV-2 virus will need to provide solid justification for the choice of variants they intend to include in their vaccines, ..... see more
Source : 'The Pink Sheet'
Europe To Resume AZ Vaccine Use After Safety Review, But Confidence Knocked
Countries in the European Union which had suspended use of AstraZeneca PLC’s COVID-19 vaccine will resume after the bloc’s medicines regulator gave it the all clear.The European Medicine ..... see more
Source : 'The Pink Sheet'
Congress Eyes Vaccine Pricing With Spotlight On Pfizer As COVID Boosters Look More Likely
US Sen. Chris Murphy, D-Conn, raised concerns that the prices of COVID-19 vaccines could soon rise, becoming unfavorable to Americans just as the country is in need of booster shots ..... see more
Source : 'The Pink Sheet'
ACA Champion Becerra Confirmed As HHS Chief
Xavier Becerra has been appointed to lead the Department of Health and Human Services by the US Senate in the most narrow and partisan vote for the position in recent ..... see more
Source : Medtech Insight
Pharma Gets Warm Spotlight At White House Event Showcasing J&J-Merck Collaboration
The pharma industry got a star turn at the White House 10 March as Johnson & Johnson CEO Alex Gorsky and Merck & Co., Inc. CEO ..... see more
Source : 'The Pink Sheet'
Medtronic CEO Regrets Not Moving More Aggressively On Some M&A Deals During Pandemic
One of Medtronic plc CEO Geoff Martha’s regrets from this past year is not moving hard enough on some mergers and acquisitions. He also says that while the ..... see more
Source : Medtech Insight
Pandemic Perspectives: Riding The Waves Of Asia’s Healthtech Innovation Explosion
Flexible approaches to business were required to ensure the vital continuity of contact between start-ups and investors was maintained during the worst phases of the COVID-19 lockdown. Seemant Jauhari, managing ..... see more
Source : Medtech Insight
Eight Themes That Will Shape Biopharma In Transformational 2021
“2021 will be a transformative year for biopharma and the life sciences. It will be the year where the credibility and power of science applied to human health will shine.” ..... see more
Source : IN VIVO